The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prevalence of residual tumor in the prostate after contemporary systemic therapy.
 
Yao Zhu
No Relationships to Disclose
 
Beihe Wang
No Relationships to Disclose
 
Jun Luo
Honoraria - Gilead Sciences; Sanofi
Consulting or Advisory Role - Janssen Oncology; Sun Pharma; Tokai Pharmaceuticals
Research Funding - Astellas Pharma (Inst); Gilead Sciences (Inst); Mirati Therapeutics (Inst); Orion (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Jun Luo is a co-inventor of a technology assigned to Johns Hopkins University who licensed to Tokai Pharmaceuticals. (Inst); Jun Luo is a co-inventor of a technology licensed to Qiagen (Inst)
 
Stephen J. Freedland
Stock and Other Ownership Interests - Armune Bioscience; Parallel6
Consulting or Advisory Role - Armune Bioscience; Astellas Pharma; Bayer; Dendreon; GenomeDx; Janssen Biotech; MDxHealth; Medivation; Parallel6; Sanofi
Research Funding - Amgen (Inst); Bayer (Inst); Dendreon (Inst); GenomeDx (Inst); Janssen Biotech (Inst); MDxHealth (Inst); Metabolon (Inst); Mitomics (Inst); Myriad Genetics (Inst); OPKO Diagnostics (Inst); POM Wonderful (Inst); Progenika (Inst)
Travel, Accommodations, Expenses - GenomeDx; Myriad Genetics; Sanofi
 
Dingwei Ye
No Relationships to Disclose